JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
General Health

Transglutaminase: What Patients Need to Know

9 min read Published August 19, 2026
Medical professionals and patients in a hospital waiting area.
Quick answer

Tissue transglutaminase, or tTG, is an enzyme found in many tissues throughout the body. tTG antibody blood tests are commonly used as an initial screening test for celiac disease.

Key Takeaways

  • Tissue transglutaminase, or tTG, is an enzyme found in many tissues throughout the body.
  • tTG antibody blood tests are commonly used as an initial screening test for celiac disease.
  • A positive transglutaminase result does not confirm celiac disease on its own and usually needs further assessment.
  • People should continue eating gluten before celiac blood testing unless a clinician advises otherwise.
  • Low total IgA levels can affect test accuracy, so clinicians may order additional antibody tests.

Medically reviewed by the Acıbadem International Medical Board — August 2, 2026

Dr. Bahadır Kaynarkaya, MD Dr. Şule Eren, MD

Transglutaminase is a naturally occurring enzyme involved in tissue repair and other body processes. In healthcare, the term most often refers to tissue transglutaminase antibody testing, a blood test used to help evaluate possible celiac disease.

What Is Transglutaminase?

Transglutaminase is a group of enzymes that help proteins bind together. These enzymes have several normal roles in the body, including supporting wound healing, tissue repair, and the stability of cells and connective tissues. Different forms of transglutaminase are found in different parts of the body.

When patients hear the term in a medical setting, it most often relates to tissue transglutaminase, also called tTG. The immune system may produce antibodies against tissue transglutaminase in people with celiac disease. For this reason, a transglutaminase antibody test is a useful tool when a clinician is investigating whether gluten may be triggering an immune reaction in the small intestine.

Transglutaminase itself is not a diagnosis, symptom, or treatment. It is an enzyme and a laboratory target. A test result must be considered alongside a person’s symptoms, medical history, diet, family history, physical examination, and, when needed, further testing.

Why Is a Transglutaminase Test Performed?

Laboratory technician operating a medical analyzer machine at Acibadem Hospitals.

The most commonly ordered test is the tissue transglutaminase immunoglobulin A antibody test, often written as tTG-IgA. It checks whether the blood contains antibodies that react to tissue transglutaminase. This is generally the preferred first blood test for celiac disease in people who are eating gluten and who have normal levels of immunoglobulin A, or IgA.

Celiac disease is an autoimmune condition in which gluten causes inflammation and damage to the lining of the small intestine. Gluten is a protein found in wheat, barley, and rye. Over time, untreated disease can interfere with nutrient absorption and may contribute to problems such as iron deficiency, reduced bone strength, delayed growth in children, or ongoing digestive symptoms.

A clinician may request transglutaminase testing for a wide range of concerns. These may include persistent diarrhea or constipation, bloating, abdominal pain, unexplained weight loss, fatigue, iron-deficiency anemia, mouth ulcers, an itchy blistering rash, or abnormal liver blood tests. Testing can also be considered when a close relative has celiac disease, even if symptoms are mild or absent.

  • Chronic digestive discomfort, bloating, or altered bowel habits
  • Unexplained iron deficiency or anemia
  • Difficulty gaining weight, poor growth, or delayed puberty in children
  • Low bone density or repeated fractures without a clear cause
  • A first-degree relative with celiac disease

Understanding tTG-IgA, tTG-IgG, and Total IgA

Doctor consulting with a patient in a medical office at Acibadem Hospitals Group.

The tTG-IgA test is highly useful for identifying people who may have celiac disease, but it is not the only relevant laboratory result. Clinicians often order a total IgA level at the same time. This is because some people have IgA deficiency, meaning their body makes very little IgA. In this situation, a tTG-IgA result can be falsely negative.

If IgA deficiency is present or suspected, a clinician may use IgG-based tests instead. These can include tTG-IgG or deamidated gliadin peptide IgG, often called DGP-IgG. The best combination of tests depends on the person’s age, symptoms, immune status, and previous results.

Laboratories may report results as negative, weakly positive, positive, or strongly positive, with a numerical value and a reference range. These ranges differ among laboratories because testing methods are not identical. Rather than comparing a number with results found online, patients should discuss their own laboratory report with the clinician who ordered it.

Importantly, antibody testing is most accurate when the person is regularly consuming gluten. Beginning a gluten-free diet before testing may lower antibody levels and make celiac disease harder to identify. Anyone considering dietary changes because of symptoms should seek medical advice first whenever possible.

What Can Positive or Negative Results Mean?

A positive tTG antibody result increases the likelihood of celiac disease, particularly when antibody levels are clearly elevated and symptoms or risk factors are present. However, it does not independently establish a diagnosis in every adult. A gastroenterology specialist may recommend an upper endoscopy with small-intestinal biopsies to look for characteristic changes in the intestinal lining.

In selected children with very high antibody levels and supporting test results, clinicians may sometimes diagnose celiac disease without biopsy under carefully defined pediatric guidance. This decision is specialized and should be made by an experienced pediatric gastroenterology team. The approach is not automatically appropriate for adults or for every child.

A negative test makes celiac disease less likely, but it does not exclude it completely. False-negative results may occur if a person has already reduced gluten intake, has IgA deficiency, has early or mild disease, or is taking medicines that affect immune activity. If symptoms remain concerning, a clinician may repeat testing, use different antibody tests, consider genetic testing, or investigate other causes.

Occasionally, transglutaminase antibodies can be positive in people who do not have celiac disease. Other autoimmune conditions, chronic liver conditions, infections, and certain inflammatory disorders can sometimes affect results. This is why clinical interpretation and appropriate confirmation are essential before making long-term dietary changes.

Preparing for the Test and What Happens Next

A transglutaminase test is a routine blood test. A healthcare professional takes a blood sample from a vein, usually in the arm, and sends it to a laboratory. Fasting is typically not required unless other blood tests ordered at the same time require it. The blood draw itself is brief; mild discomfort, bruising, or lightheadedness can occur but are usually temporary.

Before testing, patients should tell their clinician whether they have been avoiding gluten or eating only small amounts of it. They should also mention known immune conditions, liver disease, and medicines that may influence immune responses. It is generally important not to start a gluten-free diet before the evaluation is complete unless a clinician has advised otherwise.

If the result suggests celiac disease, the next step may be referral to a gastroenterologist. Further assessment can include endoscopy and biopsy, nutritional blood tests, and discussion of family screening. Testing for genetic markers called HLA-DQ2 and HLA-DQ8 may be useful in some uncertain situations; their absence makes celiac disease very unlikely, while their presence alone does not diagnose it.

Once celiac disease has been confirmed, follow-up usually includes dietary education, assessment for nutrient deficiencies, and repeat antibody testing in some cases. Antibody levels often fall after gluten is removed from the diet, but follow-up plans should be individualized.

Treatment and Everyday Care if Celiac Disease Is Confirmed

The only established treatment for celiac disease is a strict, lifelong gluten-free diet. This means avoiding foods and ingredients made from wheat, barley, and rye. Oats can be suitable for many people when they are certified gluten-free, but this should be discussed with a healthcare professional because regular oats can be contaminated with gluten during production.

A gluten-free diet can support healing of the small intestine and improve symptoms and nutrient absorption. It requires more than simply avoiding bread or pasta: gluten may be present in sauces, soups, processed foods, supplements, medicines, and foods affected by cross-contact during preparation. A registered dietitian with experience in celiac disease can provide practical, personalized guidance.

People with newly diagnosed celiac disease may need evaluation for low iron, folate, vitamin B12, vitamin D, calcium, and other nutrients. Supplements may be recommended when a deficiency is identified, but they should not replace a careful gluten-free eating plan or medical follow-up.

It is not advisable to adopt a restrictive gluten-free diet solely because of a positive screening test or vague symptoms without proper assessment. Other digestive conditions, including food intolerances and inflammatory disorders, can cause similar symptoms but require different care. A multidisciplinary evaluation can help patients reach a clear diagnosis and avoid unnecessary dietary restriction.

When to Seek Medical Care

Medical advice is appropriate when digestive symptoms continue for several weeks, recur frequently, or interfere with daily life. A person should also arrange an assessment for unexplained fatigue, iron deficiency, unintentional weight loss, persistent diarrhea, repeated abdominal pain, or signs of poor nutrition. Children should be assessed if they have poor growth, delayed development, chronic bowel symptoms, or ongoing feeding difficulties.

Prompt medical attention is important for severe dehydration, black or bloody stools, vomiting that prevents fluid intake, severe or worsening abdominal pain, fainting, or rapid unintentional weight loss. These symptoms can have many possible causes and deserve timely evaluation.

People with a parent, sibling, or child diagnosed with celiac disease can ask their clinician whether screening is appropriate, even if they feel well. Individuals should not stop eating gluten before discussing testing, as this can reduce the accuracy of transglutaminase antibody results.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients with digestive symptom assessment, celiac disease testing, and individualized follow-up when clinically appropriate.

Frequently asked questions

What is a normal transglutaminase level?

A normal result is usually reported as negative or below the laboratory’s reference cutoff. Exact numerical ranges vary by laboratory and by the testing method used. A clinician should interpret the result together with symptoms, gluten intake, and other blood tests.

Does a positive transglutaminase test mean a person has celiac disease?

A positive result makes celiac disease more likely, but it may not confirm the diagnosis by itself. Further antibody tests, specialist assessment, and sometimes a small-intestinal biopsy may be needed. Other health conditions can occasionally contribute to a positive result.

Should a person stop eating gluten before a tTG test?

No, in most cases a person should continue eating gluten until testing is completed and a clinician gives advice. Avoiding gluten beforehand can lower antibody levels and lead to a falsely negative result. Anyone already following a gluten-free diet should tell their clinician before testing.

Can transglutaminase antibodies be negative in celiac disease?

Yes. A negative result can occur if gluten intake is low, if the person has IgA deficiency, or if the disease is mild or early. When symptoms or risk factors remain strongly suggestive, a clinician may order additional tests or refer the person to a gastroenterologist.

What is the difference between tTG-IgA and tTG-IgG?

tTG-IgA is the preferred initial blood test for most people being evaluated for celiac disease. tTG-IgG may be useful for people with IgA deficiency or in specific clinical situations. Total IgA testing helps the clinician choose and interpret the most appropriate antibody test.

Can transglutaminase testing diagnose gluten sensitivity?

Transglutaminase antibody testing is designed primarily to assess celiac disease, not non-celiac gluten sensitivity. There is no single blood test that confirms non-celiac gluten sensitivity. Celiac disease and wheat allergy should be evaluated before this diagnosis is considered.

References

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • American College of Gastroenterology
  • European Society for Paediatric Gastroenterology Hepatology and Nutrition
  • Celiac Disease Foundation
  • Mayo Clinic Laboratories

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page
Was this content helpful?
Your feedback helps us improve.
Eda Nur Şeker
Eda Nur Şeker, Nurse
Author
View profile →
Keep Reading

More from the Health Library

Specialists

Related Specialists

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.